Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market

News   May 15, 2013

 
Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market
 
 
 

RELATED ARTICLES

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

Innovative ALS Therapy Startup Wins Golden Ticket Funding From Amgen

News

Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.

READ MORE

Children With Congenital Zika Virus Infection Face Serious Challenges as They Age

News

The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE